Related Experiment Video

Updated: May 20, 2025

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research
08:53

In Vivo Immunofluorescence Localization for Assessment of Therapeutic and Diagnostic Antibody Biodistribution in Cancer Research

Published on: September 16, 2019

8.9K

[Help with nibs and mabs: targeted cancer therapies for non-oncologists]

Matthijs Plas1,2, K Esther Broekman1, Thijs H Oude Munnink3

  • 1Universitair Medisch Centrum Groningen, Groningen. Afd. Medische Oncologie.

Nederlands Tijdschrift Voor Geneeskunde
|March 27, 2025
PubMed

Insights

New targeted cancer therapies, like monoclonal antibodies, offer precise treatment but have unique side effects. Understanding these targeted therapies is crucial for all healthcare professionals managing cancer patients.

Area of Science:

  • Oncology
  • Pharmacology

Background:

  • Targeted therapies, including monoclonal antibodies and small molecules, are vital in modern cancer treatment.
  • These therapies target specific cancer cell pathways, differing from traditional chemotherapy.
  • Increasing cancer incidence and complex treatments necessitate broader oncology expertise.

Purpose of the Study:

  • To educate non-oncologists about novel targeted cancer therapies.
  • To explain the mechanisms of action for these advanced treatments.
  • To outline the potential on-target and off-target side effects associated with targeted therapies.

Main Methods:

  • Review of current literature on targeted cancer therapies.
  • Analysis of mechanisms of action for monoclonal antibodies and small molecules.
  • Compilation of clinically relevant side effects and management considerations.

Main Results:

  • Targeted therapies selectively inhibit tumor growth pathways.
  • Side effects differ from chemotherapy and require specific clinical recognition.
  • Knowledge of targeted therapy actions and adverse events is essential for healthcare providers.

Conclusions:

  • Targeted therapies represent a significant advancement in oncology.
  • Non-oncologists need foundational knowledge of targeted agents and their side effects.
  • Effective patient management requires understanding the unique profile of targeted cancer drugs.

More Related Videos

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy08:09

Validation of Nanobody and Antibody Based In Vivo Tumor Xenograft NIRF-imaging Experiments in Mice Using Ex Vivo Flow Cytometry and Microscopy

Published on: April 6, 2015

11.6K
Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody07:36

Analyzing Tumor and Tissue Distribution of Target Antigen Specific Therapeutic Antibody

Published on: May 16, 2020

5.2K

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.4K
Tumor Immunotherapy01:27

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
450
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Cancer Vaccines01:30

Cancer Vaccines

Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
310